<DOC>
	<DOCNO>NCT01898182</DOCNO>
	<brief_summary>The purpose study evaluate change severity clinical sign skin photoaging among Filipino patient use Kinerase cream ( Kinetin 0.1 % ) . This study recruit 132 subject dermatological clinic tertiary hospital Philippines period 3 month ( 12 week ) . Changes severity document use physician evaluation , self-evaluation , VISIA complexion analysis system .</brief_summary>
	<brief_title>Efficacy Safety Kinetin 0.1 % Treatment Skin Photoaging</brief_title>
	<detailed_description>This study single-arm , open-label , split-face trial subject mild moderate photoaged facial skin . The study enroll around 132 subject select private dermatology clinic tertiary hospital Philippines . Patients selected private dermatology clinic tertiary hospital screen recruited participate . They provide write consent form ( Appendix I ) include study . Following enrollment , subject return outpatient visit week 4 , 8 , 12 assessment . The whole study conduct July 2013 November 2013 . The first month would involve recruitment patient . Qualified patient start 12-week treatment period ask follow every 4 week . The last two month would data analysis , interpretation write scientific report .</detailed_description>
	<mesh_term>Skin Diseases</mesh_term>
	<mesh_term>Kinetin</mesh_term>
	<criteria>Filipino Asian female subject private clinic tertiary hospital Philippines old 35 year age less 65 year age . Subjects mild moderate cutaneous photoaging assessed investigator 's assessment 6point scale . Subjects willing sign inform consent adhere protocol requirement . Suspected porphyria , systemic cutaneous lupus erythematosus , photosensitize disorder druginduced photosensitization Chronic recur skin disease disorder Any active infectious skin disorder ( Herpes simplex , molluscum contagiosum , facial wart ) Skin cancer facial tissue Any laser/IPL/ chemical peel 2 month precede screen visit History Isotretinoin use , 6 month prior screen disease Topical tretinoin adapalene 2 month prior screen visit Used topical alphahydroxy acid skincare product month precede screen visit On antiaging product wish continue use product Requiring concurrent treatment would interfere study assessment Pregnant lactating female</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>